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Abstract: Herein we describe a new methodology for the 
asymmetric hydrogenation (AH) of 2-substituted 
pyridinium salts. An iridium catalyst based on a mixture of 
a chiral monodentate phosphoramidite and an achiral 
phosphine was shown to hydrogenate N-benzyl-2-
arylpyiridinium bromides to the corresponding N-benzyl-2-
aryl-piperidines with full conversion and good 
enantioselectivity. The mechanism of the reaction under 
optimized conditions was investigated via kinetic 
measurements and isotopic labeling experiments. Our study 
suggests that the hydrogenation starts with a 1,4-hydride 
addition and that the enantiodiscriminating step involves 
the reduction of an iminium intermediate. 
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The asymmetric hydrogenation (AH) of substituted 
N-heteroarenes is an attractive route towards chiral 
cyclic amines that are ubiquitous motifs in nature and 
in active pharmaceutical ingredients.
[ 1 ]
 Among N-
heteroarenes, 2- and 3-substituted pyridines are 
probably the most challenging AH substrates. Their 
six-membered ring has indeed an aromatic resonance 
energy close to benzene,
[ 2 ]
 and their reduction to 
piperidines requires the hydrogenation of three 
different double bonds. In addition, pyridines and 
piperidines can deactivate the catalyst via strong 
coordination to the metal center. Finally, these 
substrates also lack of secondary coordinating groups 
that can contribute to improve the enantioselectivity. 
A successful strategy in the AH of pyridines has 
been quaternization of the substrate.
[3]
 Although some 
AHs of non-quaternized pyridines have been reported 
for very specific substrates,
[ 4 ]
 most of the work 
involves pyridinium salts based on ylide formation,
[5]
 
N-benzylation
[6]
 or protonation.
[7]
 In some cases, a 
secondary coordinating group introduced during the 
quaternization appeared to be crucial to obtain high 
enantioselectivities.
[6a]
  
In 2000, chiral monodentate phosphorus ligands 
were rediscovered and appeared to be as efficient as 
bidentate ligands in AH.
[ 8 ]
 Since the active AH 
catalytic species usually contained 2 ligands per 
metal center, the use of monodentate ligands led to 
the development of the so-called mixed ligand 
strategy.
[9]
 Pioneered by the group of Reetz and us, 
this approach consists of performing the 
hydrogenation with a catalyst formed in-situ from a 
metal precursor and a mixture of 2 different 
monodentate ligands with at least one of them being 
chiral. In the reaction mixture, a catalytic species 
containing both ligands (mixed ligand catalyst) is 
formed and in some cases exhibits improved 
performances compared to the corresponding single 
ligand species.
[9]
 Here we report the application of the 
mixed ligand strategy in the AH of 2-substituted N-
benzylated pyridinium salts using a catalyst formed in 
situ from [Ir(cod)Cl]2, a chiral phosphoramidite 
[10]
 
and an achiral phosphine. While the mechanism of 
the AH of N-heteroarenes has been extensively 
studied,
[ 11 ]
 we noticed that mechanistic studies 
dealing with pyridine substrates were scarce.
[ 12 ]
 
Therefore we performed a range of experiments to 
uncover the mode of action of our most efficient 
mixed ligand catalyst. 
N-Benzyl-2-phenylpyiridinium bromide (1a), 
prepared by reaction of 2-phenylpyridine with benzyl 
bromide, was chosen as model substrate. [Ir(cod)Cl]2 
was selected as metal precursor. An initial screening 
of 24 different monodentate chiral phosphoramidites 
was performed using high-throughput 
experimentation (see Supporting Information).  Three 
BINOL-based phosphoramidites were selected as 
starting point for a mixed ligand approach: PA2 and 
PA3, which were identified as the best performing 
  2 
ligands (Table 1, entries 2-3) albeit with only modest 
enantioselectivities (up to 52% ee), and PipPhos 
(PA1, entry 1) which gave relatively good results and 
is one of the most common phosphoramidites.  
Table 1. Selected results for the ligand screening in the 
AH of 1a to 2a.
[a]
  
 
Entry 
PA 
[equiv./Ir]
[b] 
PR3, R = 
[equiv./Ir]
[b]
 
Yield 
[%]
[c]
 
ee 
[%]
[c]
 
1 PA1 [2] - 99 30 
2 PA2 [2] - 49 -52 
3 PA3 [2] - 86 39 
4 PA1 [2] Ph [1] 94 31 
5 PA2 [2] Ph [1] 87 -49 
6 PA3 [2] Ph [1] 88 50 
7 PA2 [2] p-MeOC6H4 [1] 88 -56 
8 PA3 [2] p-MeOC6H4 [1] 86 55 
9 PA2 [2] p-ClC6H4 [1] 51 -54 
10 PA3 [2] p-ClC6H4 [1] 47 56 
11 PA2 [2] p-CF3C6H4 [1] 83 -58 
12 PA3 [2] p-CF3C6H4 [1] 86 60 
13 PA3 [1] - 60 17 
14 PA3 [4] - 31 2 
15 - p-CF3C6H4 [1] 3 - 
16 - p-CF3C6H4 [2] 2 - 
17 PA3 [1] p-CF3C6H4 [1] 99 77 
18 PA3 [1] p-CF3C6H4 [2] 71 77 
 
[a]
  Reaction conditions: 1a (0.05 mmol), [Ir(cod)Cl]2 (1 
mol%), phosphoramidite (PA), phosphine (PR3), DCM 
(1 mL), 50 °C, 50 bar H2, 18 h. 
[b]
  Equivalents of ligand per atom of iridium. 
[c]
  Determined by chiral GC analysis and dodecane as 
internal standard. Positive values correspond to R 
configuration. 
 
All combinations between the three most 
enantioselective phosphoramidites PA1-3 and 13 
different achiral phosphines and phosphites (see 
Supporting Information) were tested with [Ir(cod)Cl]2 
as the metal precursor. Considering that the 
phosphine is a stronger donor ligand than the 
phosphoramidite, a phosphoramidite:phosphine ratio 
of 2:1 was used to promote the formation of the 
mixed ligand catalyst. Gratifyingly, some 
improvements in terms of activity and 
enantioselectivity were obtained upon addition of 
aromatic phosphines (entries 4-12). The 
triphenylphosphine bearing trifluoromethyl groups in 
the para-position led to the best enantioselectivities 
(entries 11 and 12). Remarkably, the three 
phosphoramidites PA1-3 were differently affected by 
combination with the same achiral phosphine (entries 
4-6): no significant change was observed when PA1 
was combined with PPh3 (entry 1 vs 4). With PA2, 
the addition of PPh3 improved the activity without 
affecting the enantioselectivity (entry 2 vs 5). On the 
contrary, the addition of PPh3 to PA3 improved the 
enantioselectivity without affecting the yield (entry 3 
vs 6).  
The ratio between iridium and the two ligands was 
investigated with PA3 and P(p-CF3C6H4)3. For the 
phosphoramidite ligand alone, the optimal amount 
was 2 equivalents per iridium (entries 3, 13 and 14). 
A larger excess of PA3 led to lower yields and 
enantioselectivities (entry 14). Remarkably, the 
achiral phosphine used alone led to no conversion 
(entries 15-16). Since the Ir-phosphine complex 
appeared to be inactive, we investigated lower 
phosphoramidite:phosphine ratios. The optimal 
iridium:PA3:phosphine ratio was determined to be 
1:1:1 (entry 17), leading to full conversion to 2a and 
77% ee. An excess of phosphine or phosphoramidite 
(entries 12-18) led to a decrease in activity, probably 
due to the saturation of the metal complex by the 
extra ligand. In agreement with the lack of activity of 
the phosphine homo-complex, an excess of phosphine 
did not affect the enantioselectivity (entry 18). On the 
other hand, an excess of phosphoramidite led to a 
lower ee (entry 12) which is also consistent with the 
Ir complex containing two phosphoramidites being 
less enantioselective. 
An extensive screening of solvents and additives 
did not result in an improved catalytic performance of 
the Ir/PA3/P(p-CF3C6H4)3 system. Decreasing the 
pressure of H2 led to a lower conversion without 
affecting the enantioselectivity. Decreasing the 
temperature improved the ee to 83% but at the 
expense of the conversion (see Supporting 
Information).  
The substrate scope was investigated to some 
extent with the optimized system (Table 2). Indeed, 
the mixed ligand catalyst was efficient for a range of 
2-arylpyridinium salts. Yields and enantioselectivities 
were very similar for these substrates, i.e. not 
drastically influenced by the electronic properties of 
the aryl substituent (Table 2, entry 1-6). Increasing 
the steric bulk of the aryl substituent let to a decrease 
of the enantioselectivity (Table 2, entry 7). 
Table 2. Substrate screening for AH of N-benzyl-2-
arylpyridinium salts.
[a]
  
 
Entry Ar Yield [%]
[b] 
ee [%]
[b]
 
1 Ph (1a) 99 (92)
c)
 77 (R) 
2 4-MeC6H4 (1b) 98 71 (+) 
3 4-MeOC6H4 (1c) 99 82 (+) 
4 3,5-di-MeOC6H3 (1d) 97 70 (+) 
  3 
5 4-CF3C6H4 (1e) 98 74 (+) 
6 4-ClC6H4 (1f) 99 74 (+) 
7 2-naphthyl (1g) 99 58 (–) 
[a]
  Reaction conditions: 1 (0.1 mmol), [Ir(cod)Cl]2 (1 
mol%), PA3 (2.2 mol%), P(p-CF3C6H4)3 (2.2 mol%), 
DCM (2 mL), 50 °C, 50 bar H2, 18 h. 
[b]
  Yield and ee determined by chiral GC, HPLC or SFC 
with dodecane as internal standard. 
[c]
  In brackets, isolated yield of a 500 mg scale reaction. 
 
A mechanistic study was performed with the 
optimized catalyst. The AH of pyridinium salt 1a was 
monitored over time by GC and NMR (Figure 1). The 
substrate was fully consumed in roughly 10 hours, 
with concomitant formation of piperidine 2a, whose 
ee remains almost constant during the course of the 
reaction. The reaction profile fits well with a 1
st
 order 
reaction, with a small induction period during the first 
minutes.  
 
Figure 1. Evolution of the yield and ee of different 
reaction species over time. Reaction conditions: 1a (1.5 
mmol), [Ir(cod)Cl]2 (1 mol%), PA3 (2.2 mol%), P(p-
CF3C6H4)3 (2.2 mol%), DCM (30 mL), 50 °C, 50 bar H2, 
10 h. Consumption of 1a determined by NMR with 
dimethyl terephthalate as internal standard. Yield and ee of 
2a and TH monitored by chiral GC analysis with dodecane 
as internal standard. 
A reaction intermediate (labeled TH in Figure 1) 
was detected by GC. Its concentration reaches a 
maximum after 1.5 hours. Although it could not be 
isolated, its mass (m/z = 249) determined by GC-MS 
was consistent with a N-benzylated 
tetrahydropyridine isomer. NMR analysis allowed us 
to identify TH as N-benzyl-6-phenyl-1,2,3,4-
tetrahydropyridine (Figure 1, see Supporting 
Information). During the course of the reaction, the 
sum of 1a, 2a and TH matched well with the initial 
amount of substrate used, suggesting that no other 
intermediates are formed and that the hydrogenation 
of TH is the rate limiting step. 
To get further insight into the mechanism, two 
isotopic labeling experiments were conducted 
(Scheme 1). When the optimized reaction was carried 
out with H2 in the presence of CD3OD (Scheme 1A), 
a high deuterium incorporation was observed at C3 
(1.07 deuteriums) and C5 (0.30 deuteriums), 
compared to the other carbons (< 0.12 deuteriums 
each). This suggests that enamine-iminium 
tautomerizations take place during the reaction 
leading to the addition of a proton from the reaction 
medium into the position 3 and 5 in agreement with 
previous studies for other N-heteroaromatic 
substrates.
[11]
  
 
Scheme 1. Isotopic labeling experiment for the AH of N-
benzyl-2-phenylpyridinium bromide 1a in the presence of 
CD3OD (A) or D2 (B). 
The low deuterium incorporation at C4 is 
consistent with an initial 1,4-hydride addition to 1a 
leading to the formation of N-benzyl-2-phenyl-1,4-
dihydropyridine (DH, Scheme 2). The 
dihydropyridine DH can tautomerize into the two 
iminium ions DH’ and DH”. Since TH is the only 
detectable intermediate, it is reasonable to think that 
the 1,2-hydride addition to DH' occurs faster than to 
the more sterically hindered DH”. The difference of 
reactivity between DH’ and DH” is also consistent 
with the higher deuterium incorporation at C3 
compared to C5. Since DH” is a longer-living 
intermediate, it can incorporate more deuterium at C3 
via multiple enamine-iminium interconversions. 
A second isotopic labeling experiment was 
performed by reacting 1a with D2 gas under the 
optimized conditions (Scheme 1B): all the ring 
positions were deuterated, with a total amount of five 
deuterium atoms incorporated. No ring-face 
preference for the deuterium incorporation is 
observed in any of the carbons suggesting that the 
stereogenic center is not formed until the last step. 
Based on these experimental results, the following 
mechanism can be proposed (Scheme 2): an initial 
  4 
1,4-hydride addition to 1a, forming the 
dihydropyridine DH; the rapid hydrogenation of DH 
into TH via an iminium intermediate DH’; the 
enantioselective 1,2-hydride addition to the iminium 
TH’ to the final piperidine 2a. 
 
Scheme 2. Proposed mechanism for the asymmetric 
hydrogenation of 1a. 
In conclusion, we have developed a new catalytic 
system based on a mixture of ligands for the 
asymmetric hydrogenation of 2-arylpyridines. Using 
an iridium complex in the presence of two different 
monodentate ligands (a chiral phosphoramidite and 
an achiral phosphine), full conversions and ee’s up to 
82% were obtained. A mechanistic study was 
performed and allowed us to propose DH and TH as 
the intermediates in the hydrogenation of 1a to 2a. 
The mixed ligand strategy is attractive since a large 
number of catalytic systems can be generated through 
the simple combination of monodentate ligands. 
Therefore we anticipate that via high-throughput 
screening, novel mixed ligands catalysts for the 
hydrogenation of related substrates will soon be 
discovered. 
Experimental Section 
Inside the N2 glovebox, a solution of [Ir(cod)Cl]2 (0.0015 
mmol), PA3 (0.0033 mmol) and P(p-CF3C6H4)3 (0.0033 
mmol) in DCM (1 mL) was stirred at 45 °C for 30 min. 
The preformed catalyst was added to a 5 mL vial 
containing a solution of the corresponding N-benzyl-2-
arylpyridinium bromide (0.15 mmol) in DCM (2 mL). The 
vial was capped with a PTFE septum, removed from the 
glovebox and placed into a Premex 96er Multireaktor. 
After flushing it 5 times with N2 (10 bar) and 5 times with 
H2 (10 bar), it was pressurized to 50 bar of H2 and stirred at 
50 °C for 18 h. The crude mixture was washed with a 
saturated aqueous solution of Na2CO3 and extracted with 
DCM. The organic extracts were dried, concentrated and 
purified by flash column chromatography Hexane/EtOAc 
(from 99:1 to 95:5). 
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